US2019029986A1PendingUtilityA1

Therapeutic regimen and methods for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency

51
Assignee: NOVELION THERAPEUTICS INCPriority: Apr 19, 2010Filed: May 1, 2018Published: Jan 31, 2019
Est. expiryApr 19, 2030(~3.8 yrs left)· nominal 20-yr term from priority
A61P 27/02A61K 31/11A61K 9/0048A61K 31/22A61K 9/0095A61K 31/215A61K 31/21A61K 9/0053A61K 31/222Y10S514/912
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed herein are therapeutic regimens for treating or ameliorating a visual disorder associate with an endogenous retinoid deficiency in a subject by administering a therapeutically effective amount of a synthetic retinal derivative or a pharmaceutically acceptable composition comprising a synthetic retinal derivative according to the therapeutic regimen which leads to local recovery of visual functions such as visual fields, visual acuity and retinal sensitivity, among others.

Claims

exact text as granted — not AI-modified
1 . A method for treating a patient suffering from the loss or impairment of vision caused by a retinoid deficiency disorder, comprising the steps of:
 a) administering to the patient an initial therapeutically effective dose of a synthetic retinal derivative that provides replacement for endogenously produced 11-cis-retinal,   b) refraining from administering to the patient an additional therapeutically effective dose of synthetic retinal derivative for a resting interval of at least 1 month,   c) administering to the patient an additional therapeutically effective dose of a synthetic retinal derivative.   
     
     
         2 - 33 . (canceled) 
     
     
         34 . A kit for use in the treatment or amelioration of a visual disorder associated with an endogenous retinoid deficiency in a subject, the kit comprising:
 (i) a therapeutic effective amount of a synthetic retinal derivative, or a therapeutic effective amount of a pharmaceutically acceptable composition comprising a synthetic retinal derivative; and   (ii) instructions for administering the synthetic retinal derivative or the pharmaceutically acceptable composition to the subject   
     
     
         35 . A method of preparing a medicament for administration to a subject having an endogenous retinoid deficiency, the method comprising formulating a synthetic retinal derivative with a pharmaceutically acceptable vehicle.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.